Rare Disease Clinical Trial Success with Patient-Defined Outcomes
Rare Disease Clinical Trial Success with Patient-Defined Outcomes How Patient-Defined Outcomes Drive Rare Disease Trial Success Introduction: Shifting the Clinical Trial Paradigm Traditional clinical trials rely on standardized clinical endpoints such as biomarker levels, progression-free survival, or functional test scores. While scientifically robust, these endpoints may not fully capture the lived experience of patients with…
Read More “Rare Disease Clinical Trial Success with Patient-Defined Outcomes” »